Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children
NCT ID: NCT03565770
Last Updated: 2025-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
106 participants
INTERVENTIONAL
2018-09-29
2021-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that the proposed coaching would allow to improve the patient glycemic control not only during this coaching, but also, to bring long lasting improvement following the coaching.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care + coaching
minor patients with a type 1 diabetes, having therapy adjustment difficulties, receiving individual coaching and usual standard care
individual coaching
coaching on the phone or with messages on line twice a month in order to help patients to adjust their insulin doses and fill in their self-assessment test.
Standard care
completion of the self-assessment test at inclusion, at M6 and M12 for all study participants
Standard care
minor patients with a type 1 diabetes, having therapy adjustment difficulties, receiving usual standard care only.
Standard care
completion of the self-assessment test at inclusion, at M6 and M12 for all study participants
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
individual coaching
coaching on the phone or with messages on line twice a month in order to help patients to adjust their insulin doses and fill in their self-assessment test.
Standard care
completion of the self-assessment test at inclusion, at M6 and M12 for all study participants
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any diabetic patient (girl or boy) who doesn't master the adjustments of the treatment according to the investigator's judgment (non-adaptations of the treatment between 2 consultations or mistakes in adapting the insulin doses, not taking properly into account previous days tendencies, food, or activities) and/or average HbA1c of more than 8% during the last year.
* The patient, his 2 parents or legal representatives all agree to participate in the research
* Absence of justice protection measures
* Good predictable observance of the protocol
* Family can be reached by phone during the coaching timetables working hours or must be listed on the platform line " MyDiabby ".
Exclusion Criteria
* Major understanding difficulties from the relatives (difficulties in understanding French or what anticipatory adaptation means)
* The child or parents or legal representatives refuse to participate and to sign a consent
* Contact on the phone or on the platform impossible according to the protocol procedures
* Patient non-registered under Social Security
* Patient under justice protection measures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine Lefe, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Jeanne de Flandres
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A03021-52
Identifier Type: OTHER
Identifier Source: secondary_id
2016_65
Identifier Type: -
Identifier Source: org_study_id